| Literature DB >> 2464723 |
D Batinić1, R Tindle, D Boban, A Tiefenbach, L Rajić, B Labar, D Nemet, M Boranić.
Abstract
The expression of progenitor cell-associated antigen CD34, defined with monoclonal antibody BI-3C5, was investigated in cells from 109 patients with leukaemia. No reactivity was found in chronic leukaemias, whereas 31% of acute myelogenous leukaemia (AML) and most non-T, non-B acute lymphoblastic leukaemia (ALL) expressed CD34. Examples of BI-3C5+ AML included M1 and M2 FAB types only; all but one were myeloperoxidase positive. In combination with pan-myeloid markers, BI-3C5 is useful for identification of immature myeloid cells.Entities:
Mesh:
Substances:
Year: 1989 PMID: 2464723 DOI: 10.1016/0145-2126(89)90035-0
Source DB: PubMed Journal: Leuk Res ISSN: 0145-2126 Impact factor: 3.156